Type 2 diabetes; Medication adherence; Community pharmacist; Mobile health application; Therapeutic patient education
Abstract :
[en] Background: Prevalence of type 2 diabetes is high in Belgium (estimated at over 10%, 1 patient out of 3 being unaware of their diagnosis). Management based on a change of lifestyle and the adoption of health-promoting behaviors, supplemented when needed with drug treatment, prevents complications, improves the patient's quality of life and reduces mortality. Multidisciplinary patient support is essential. In this, pharmacists have a key role, e.g. through therapeutic patient education activities, in which they are increasingly involved. Moreover, research suggests that the use of mobile technologies can be a useful tool for helping patients with their daily life and disease management.
Objectives: This study aims at exploring the bene ts of community pharmacist follow-up supported by the use of mobile technologies in the monitoring of individuals with type 2 diabetes. The presented intervention aimed to reinforce the patients' willingness to actively participate in the management of their disease and to adopt favorable health behaviors, in order to increase their level of medication adherence.
Methods: A quantitative quasi-experimental study was conducted in community pharmacies throughout Belgium over a 6-month period with 3 data collection periods (before, during and after the intervention). Primary out- comes, related to the level of medication adherence, and secondary outcomes, considered as markers of the patient's overall health, were analyzed. In addition, qualitative data concerning participants' opinions on their experience were collected.
Results: 66 patients participated in the study, with 50 remaining after 3 months and 46 completing the entire study. Statistical analyses did not show an improvement in the level of medication adherence. This parameter was high from the beginning, re ecting patients with controlled diabetes. However, statistically signi cant re- sults were observed for systolic blood pressure and waist circumference (both improved), while other outcomes showed a positive trend or remained stable. Patient follow-up by the pharmacist was a positive experience for both parties which noted their interest and satisfaction for the project.
Conclusions: Although clinical results are not conclusive, patients were motivated and the attrition rate was low. Participants showed their interest in participating in this kind of project, opening up opportunities for further studies in the community pharmacy setting. As front-line health professionals, community pharmacists certainly have a key-role to play in therapeutic patient education and mobile technologies could be additional tools in this process.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Lallemand, Alice ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Université de Liège - ULiège > Département de pharmacie > Pratiques pharmaceutiques officinales
Verrue, C.
Santi, A.
Delhaye, N.
Willaert, M.
Attipoe, A.
Tomas, M.
Philippe, Geneviève ; Université de Liège - ULiège > Département de pharmacie > Pratiques pharmaceutiques officinales ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Language :
English
Title :
Evaluation of community pharmacist follow-up supported by the use of healthcare technology for type 2 diabetes patients
Publication date :
December 2023
Journal title :
Exploratory Research in Clinical and Social Pharmacy
For a Healthy Belgium, Diabetes. https://www.healthybelgium.be/en/health-status/non-communicable-diseases/diabetes (accessed Dec. 01, 2022).
Organisation mondiale de la Santé, Diabète. https://www.who.int/fr/news-room/fact-sheets/detail/diabetes, Sep. 16, 2022 (accessed Dec. 01, 2022).
Organisation mondiale de la Santé, Rapport mondial sur le diabète. 2016, Organisation mondiale de la Santé, Genève Accessed: Dec. 01, 2022. [Online]. Available: https://apps.who.int/iris/handle/10665/254648.
Pillon, F., Tan, K., Jouty, P., Frullani, Y., Rôle du pharmacien dans la prise en charge du patient diabétique de type 2. Actual Pharmacol 53:541 (Dec. 2014), 29–34, 10.1016/j.actpha.2014.10.006.
Pousinho, S., Morgado, M., Falcão, A., Alves, G., Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm 22:5 (May 2016), 493–515, 10.18553/jmcp.2016.22.5.493.
van Eikenhorst, L., Taxis, K., van Dijk, L., de Gier, H., Pharmacist-led self-management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis. Front Pharmacol, 8, 2017, 891, 10.3389/fphar.2017.00891.
Michiels, Y., et al. Impact of a community pharmacist-delivered information program on the follow-up of Type-2 diabetic patients: a cluster randomized controlled study. Adv Ther 36:6 (Jun. 2019), 1291–1303, 10.1007/s12325-019-00957-y.
Nogueira, M., Otuyama, L.J., Rocha, P.A., Pinto, V.B., Pharmaceutical care-based interventions in type 2 diabetes mellitus : a systematic review and meta-analysis of randomized clinical trials. Einstein 18 (2020), 1–14, 10.31744/einstein_journal/2020RW4686.
Bingham, J.M., et al. Impact of telehealth interventions on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia: a systematic review. Ann Pharmacother 55:5 (May 2021), 637–649, 10.1177/1060028020950726.
Comunicare Solutions, Comunicare : Compagnon du parcours de soin. https://www.comunicare.be/ (accessed Aug. 24, 2023).
Miyamoto, S., et al. Empowering diabetes self-management through technology and nurse health coaching. Diabetes Educ 45:6 (Dec. 2019), 586–595, 10.1177/0145721719879421.
Bennett, G., Miller, W.R., Rollnick, S., Motivational interviewing, preparing people to change addictive behavior. New York: Guilford Press, 1991. J Community Appl Soc Psychol 2:4 (1992), 299–300, 10.1002/casp.2450020410.
Allenet, B., et al. Comment évaluer l'adhésion médicamenteuse ? Le point sur les méthodes. Ann Pharm Fr 71:2 (Mar. 2013), 135–141, 10.1016/j.pharma.2012.10.001.
Lyons, I., Barber, N., Raynor, D.K., Wei, L., The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Qual Saf 25:10 (Oct. 2016), 759–769, 10.1136/bmjqs-2015-004670.
American Diabetes Association, Standards of Medical Care in Diabetes—2013. Diabetes Care 36:S1 (Jan. 2013), S11–S66, 10.2337/dc13-S011.
Konstantinou, P., et al. A scoping review of methods used to assess medication adherence in patients with chronic conditions. Ann Behav Med 56:12 (Nov. 2022), 1201–1217, 10.1093/abm/kaab080.
Horne, R., Hankins, M., Jenkins, R., The satisfaction with information about medicines scale (SIMS): a new measurement tool for audit and research. Qual Saf Health Care 10:3 (Sep. 2001), 135–140, 10.1136/qhc.0100135.
Chan, A.H.Y., Horne, R., Hankins, M., Chisari, C., The medication adherence report scale: a measurement tool for eliciting patients’ reports of nonadherence. Br J Clin Pharmacol 86:7 (Jul. 2020), 1281–1288, 10.1111/bcp.14193.
Tommelein, E., Mehuys, E., Van Tongelen, I., Brusselle, G., Boussery, K., Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD. Ann Pharmacother 48:5 (May 2014), 589–595, 10.1177/1060028014522982.
Muralidharan, S., et al. Engagement and weight loss: results from the Mobile health and diabetes trial. Diabetes Technol Ther 21:9 (Sep. 2019), 507–513, 10.1089/dia.2019.0134.
Hammad, E.A., Yasein, N., Tahaineh, L., Albsoul-Younes, A.M., A randomized controlled trial to assess pharmacist-physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan. J Manag Care Pharm 17:4 (May 2011), 295–303, 10.18553/jmcp.2011.17.4.295.
Korcegez, E.I., Sancar, M., Demirkan, K., Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from northern cyprus: a randomized controlled trial. J Manag Care Spec Pharm 23:5 (May 2017), 573–582, 10.18553/jmcp.2017.23.5.573.
Mancia, G., et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:6 (Jun. 2007), 1105–1187, 10.1097/HJH.0b013e3281fc975a.
World Health Organization, Waist circumference and waist-hip ratio : report of a WHO expert consultation. Accessed: Jun. 29, 2023. [Online]. Available: https://apps.who.int/iris/handle/10665/44583, 2011.
Wang, W., et al. A randomized controlled trial on a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: a study protocol. J Adv Nurs 74:1 (Jan. 2018), 190–200, 10.1111/jan.13394.
Skinner, J.S., Poe, B., Hopper, R., Boyer, A., Wilkins, C.H., Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes. Diabetes Educ 41:4 (Aug. 2015), 459–465, 10.1177/0145721715587563.
Sarayani, A., et al. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice. Int J Clin Pharmacol 40:2 (Apr. 2018), 345–353, 10.1007/s11096-018-0593-0.
Polonsky, W., Henry, R., Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence 10 (Jul. 2016), 1299–1307, 10.2147/PPA.S106821.
Tajudeen, F.P., Bahar, N., Tan, M.P., Peer Mustafa, M.B., Saedon, N.I., Jesudass, J., Understanding user requirements for a senior-friendly mobile health application. Geriatrics, 7(5), Oct. 2022, 110, 10.3390/geriatrics7050110.